Eptifibatide
- Product NDC
- 70121-1002
- 11-digit product format
- 701211002
- Labeler code
- 70121
- Product ID
- 70121-1002_e8979e1f-abf6-4745-a479-8d417de3ac90
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Eptifibatide
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Amneal Pharmaceuticals LLC
- Application
- ANDA205581
- Marketing category
- ANDA
- Marketing start
- 2016-12-08
- Marketing end
- 0000-00-00
- Substance
- EPTIFIBATIDE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70121-1002 | EPTIFIBATIDE INJECTION [AMNEAL PHARMACEUTICALS LLC] | 14 | Legacy NDC | 20231226_f48ecd1e-a2c3-45d1-9e2e-d9a8fb71a770.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70121-1002-1 | 70121100201 | 1 VIAL, GLASS in 1 CARTON (70121-1002-1) > 10 mL in 1 VIAL, GLASS | 2016-12-08 | 0000-00-00 | No | No | Current |